Jason Klig

Prior to joining Kirkland, Jason’s representative matters included:

• Legg Mason, Inc. in its $6.5 billion sale to Franklin Templeton Investments
• AK Steel Corporation in its approximately $3 billion sale to Cleveland-Cliffs, Inc.
• Harbour Energy plc in its $3.2 billion acquisition of LLOG Exploration Company
• Magellan Health, Inc. in its $2.2 billion merger with Centene Corporation
• ChampionX Corporation:
  • in its sale to SLB; and
  • in the sale of U.S. Synthetic Corporation to LongRange Capital
• AltC Acquisition Corp., a SPAC sponsored by AltC Sponsor LLC (an affiliate of M. Klein and Company, LLC), in its $875 million de-SPAC merger with Oklo Inc.
• Six Flags Entertainment in its $331 million sale of seven parks to EPR Properties
• Brooks Brothers Group, Inc. in its $325 million sale to SPARC Group LLC
• Allego N.V. in its $464 million tender offer to Madeleine Charging B.V., Meridiam S.A.S. and their affiliates
• Howden Group Holdings Limited (an investee company of General Atlantic, CDPQ and Hg) in its acquisition of TigerRisk Partners, LLC
• Ontario Teachers’ Pension Plan in its acquisition of a majority stake in Vantage Elevator Solutions
• Eli Lilly and Company in an up to $1.6 billion co-development and co-commercialization collaboration with, and equity investment in, Foghorn Therapeutics Inc.
• Micron Technology, Inc. in its sale of its Lehi, UT fab for $900 million in cash
• ChargePoint, Inc. in its $295 million acquisition of has-to-be-GmbH
• Meridian Adhesives Group in its $390 million sale of Meridian Adhesives Flooring Business to Avery Dennison Corporation
• American Securities in its acquisition of RealManage, LLC
• Sanofi in its sale of Enjaymo to a subsidiary of Recordati Industrial Chimica E Farmacuetica S.p.A.
• MarketAxess Holdings Inc. in its acquisition of MuniBrokers, LLC
• Thea Pharma Inc. (a subsidiary of Laboratoires Thea SAS) in its acquisition of a portfolio of seven ophthalmic products from Akorn Pharmaceuticals
• Trebia Acquisition Corp., a SPAC sponsored by affiliates of Trasimene Capital Management and Bridgeport Partners, in its $1.4 billion business combination with System1, LLC
• Glencorein its sale of CSA copper mine in New South Wales, Australia, to Metals Acquisition Corp (d/b/a MAC), a SPAC sponsored by Green Mountain Metals, LLC
• Glencore Canada Corporation in its stalking horse bid for certain assets of Li-Cycle Holdings Corp. and certain of its subsidiaries
• Wex Health (a subsidiary of Wex Inc.) in its $180 million acquisition of Ascensus Health & Benefits line of business from Ascensus, LLC
• Digital Realty Trust, Inc. in its definitive agreements with Brookfield Infrastructure Partners L.P. and its institutional partners, Cyxtera Technologies and Digital Core REIT, that successfully resole the relationships with Cyxtera, including its (i) $459 million sale of four data centers located in California and New Jersey, (ii) $44 million purchase and termination of three of Cyxtera’s leases in Germany and Singapore, (iii) assignment to Brookfield of three leases in Los Angeles and New Jersey and (iv) purchase option to acquire from Brookfield one colocation center outside of London
• Digital Netherlands Holding B.V. (a subsidiary of Digital Realty Trust) in its $200 million acquisition of LHR! Data Center Holdings from Phoenix Parallel Global Holdings Limited (a subsidiary of Brookfield Asset Management)
• Dermira, Inc. (a subsidiary of Eli Lilly and Company) in its sale of QBREXZA
• Arcade Beauty, a leading global beauty company providing both retail and sampling solutions, in connection with its out-of-court recapitalization
• Healogics, Inc. in its debt for equity exchange and $240 million common and preferred equity investments by an investor consortium led by Clayton Dubilier & Rice, Partners Group and Northwestern Mutual, and Marathon Asset Management